RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - RAPT Therapeutics, Inc. is a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with inflammatory and immunological diseases [1][3] - The company utilizes a proprietary discovery and development platform to advance both biologics and selective small molecules aimed at normalizing critical immune drivers underlying these conditions [3] Upcoming Presentation - Brian Wong, M.D., Ph.D., President and Chief Executive Officer of RAPT Therapeutics, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025, at 9:00 a.m. Pacific Time [1]